816 filings
Page 3 of 41
8-K
x8yc7c
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
11:10am
8-K
sp4 zg6fvi
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
fnw9 zv0k2d1uj
2 Oct 23
Entry into a Material Definitive Agreement
6:03am
EFFECT
je8omyh b8uyz0yd
2 Oct 23
Notice of effectiveness
12:15am
424B3
4ngd31rxdt2aofk9ho
29 Sep 23
Prospectus supplement
4:56pm
CORRESP
knsk6fz9 m0dc
26 Sep 23
Correspondence with SEC
12:00am
8-K
ojgqw zwhcivg
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
m1jyrv9ma8khb5a8rtrf
25 Sep 23
Prospectus supplement for primary offering
6:02am
8-K
hyetjxl
20 Sep 23
Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide
7:00am
UPLOAD
djdf596y q9ij0x21lpl
20 Sep 23
Letter from SEC
12:00am
8-K
ojjkp5h vyfs
14 Sep 23
Other Events
9:00am
8-K
xs1 mjde2xc9gla
29 Jun 23
Other Events
9:00am
8-K
6wh0w1ws26xki6q
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
rh1mj8166
19 May 23
Entry into a Material Definitive Agreement
5:00pm
DEFA14A
8ap2j3nexo
28 Apr 23
Additional proxy soliciting materials
6:01am
ARS
7wyckcw4sgf lj
12 Apr 23
Annual report to shareholders
4:10pm